- Tytuł:
- Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
- Autorzy:
- Źródło:
- In Gynecologic Oncology October 2023 177:20-31
Czasopismo naukowe